Oxford Biomedica Appoints Dr Frank Mathias as Chief Executive Officer
- gdelacruz57
- Nov 23, 2022
- 1 min read
Oxford, UK, November 22, 2022 (Yahoo) -- Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a leading gene and cell therapy group, today announces the appointment of Dr Frank Mathias as Chief Executive Officer (CEO) and Board Director, effective March 2023.
Read full article here.
Comments